In vivo inhibition of platelet adhesion by a cGMP-mediated mechanism in balloon catheter injured rat carotid artery

被引:8
作者
Vemulapalli, S [1 ]
Chiu, PJS [1 ]
Kurowski, S [1 ]
Brown, A [1 ]
Hartman, BD [1 ]
Leach, MW [1 ]
机构
[1] SCHERING PLOUGH CORP,RES INST,LAFAYETTE,NJ
关键词
cyclic nucleotides; platelet adhesion; sodium nitroprusside; vascular injury; zaprinast;
D O I
10.1159/000139388
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role of cyclic guanosine monophosphate (cGMP) versus cyclic adenosine monophosphate (cAMP) mediated mechanism in modulating platelet adhesion was investigated in balloon catheter injured rat carotid arteries. Vascular injury with balloon angioplasty significantly increased the adherence of platelets to the injured carotid arteries. Intravenous infusion of zaprinast (1 mg/kg/min), a cGMP phosphodiesterase inhibitor, or sodium nitroprusside (8 mu g/kg/min), a stimulator of soluble guanylate cyclase, significantly attenuated the adherence of platelets to the injured carotid arteries. In comparison, infusion of milrinone, a cAMP phosphodiesterase inhibitor, or 8-bromo-cAMP failed to affect the platelet deposition in the injured carotid arteries. Nifedipine or aspirin also failed to attenuate the adherence of platelets to the injured carotid arteries. In conclusion, agents known to elevate intracellular platelet cGMP but not cAMP appear to afford the most effective protection in vivo against the adhesion of platelets to the vessel wall without intact endothelium.
引用
收藏
页码:235 / 242
页数:8
相关论文
共 28 条
[1]   CHARACTERIZATION OF THE CARDIOTONIC EFFECTS OF MILRINONE, A NEW AND POTENT CARDIAC BIPYRIDINE, ON ISOLATED-TISSUES FROM SEVERAL ANIMAL SPECIES [J].
ALOUSI, AA ;
STANKUS, GP ;
STUART, JC ;
WALTON, LH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (05) :804-811
[2]  
ARAKAWA H, 1992, J CARDIOVASC PHARM, V29, P731
[3]  
BADIMON L, 1992, J HYPERTENS S2, V10, P43
[4]   EFFECTS OF NITROVASODILATORS ON PLATELET CYCLIC-NUCLEOTIDE LEVELS IN RABBIT-BLOOD - ROLE FOR CYCLIC-AMP IN SYNERGISTIC INHIBITION OF PLATELET-FUNCTION BY SIN-1 AND PROSTAGLANDIN-E1 [J].
BOWEN, R ;
HASLAM, RJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (03) :424-433
[5]  
CHINTALA MS, 1994, J PHARMACOL EXP THER, V271, P1203
[6]  
Chiu P. J. S., 1994, Journal of Biomedical Science, V1, P43
[7]  
CLOWES AW, 1983, LAB INVEST, V49, P208
[8]  
COLLER BS, 1989, BLOOD, V74, P182
[10]   MODULATION OF HUMAN PLATELET ADENYLATE-CYCLASE BY PROSTACYCLIN (PGX) [J].
GORMAN, RR ;
BUNTING, S ;
MILLER, OV .
PROSTAGLANDINS, 1977, 13 (03) :377-388